Jay Backstrom T.'s Insider Trades & SAST Disclosures
Jay Backstrom T.'s most recent trade in Scholar Rock Holding Corp was a trade of 151,430 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jay Backstrom T..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | Jay T. Backstrom | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 151,430 | 151,430 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jay T. Backstrom | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 113,570 | 425,561 (1%) | 0% | 0 | Common Stock | |
| Scholar Rock Holding Corp | Jay T. Backstrom | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 36.83 per share. | 18 Feb 2025 | 18,372 | 311,991 (1%) | 0% | 36.8 | 676,622 | Common Stock |
| LAVA Therapeutics NV | Jay T. Backstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 33,390 | 33,390 | - | - | Common Shares (Right to Buy) | |
| Scholar Rock Holding Corp | Jay T. Backstrom | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.20 per share. | 16 Jan 2025 | 22,308 | 330,363 (1%) | 0% | 44.2 | 985,951 | Common Stock |
| Scholar Rock Holding Corp | Jay T. Backstrom | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 15.74 per share. | 16 Feb 2024 | 11,614 | 352,671 (1%) | 0% | 15.7 | 182,842 | Common Stock |
| Scholar Rock Holding Corp | Jay T. Backstrom | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 285,715 | 285,715 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jay Backstrom T. | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 214,285 | 364,285 (1%) | 0% | 0 | Common Stock | |
| Scholar Rock Holding Corp | Jay T. Backstrom | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jay T. Backstrom | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 150,000 | 150,000 (0%) | 0% | 0 | Common Stock | |
| Disc Medicine Inc | Jay T. Backstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2022 | 7,000 | 7,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jay T. Backstrom | CEO-Elect | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 1,000,000 | 1,000,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges